Cargando…
Reduction in atherosclerotic events: a retrospective study in an outpatient cardiology practice
INTRODUCTION: Although atherosclerotic disease cannot be cured, risk of recurrent events can be reduced by application of evidence-based treatment protocols involving aspirin, beta blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and statin medications. We studied...
Autores principales: | Mercando, Anthony D., Lai, Hoang M., Aronow, Wilbert S., Kalen, Phoenix, Desai, Harit V., Gandhi, Kaushang, Sharma, Mala, Amin, Harshad, Lai, Trung M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309438/ https://www.ncbi.nlm.nih.gov/pubmed/22457676 http://dx.doi.org/10.5114/aoms.2012.27282 |
Ejemplares similares
-
The impact of statin therapy on long-term cardiovascular outcomes in an outpatient cardiology practice
por: Lai, Hoang M., et al.
Publicado: (2012) -
The impact of statin therapy on long-term cardiovascular outcomes in an outpatient cardiology practice
por: Lai, Hoang M., et al.
Publicado: (2011) -
Risk factor reduction in progression of angiographic coronary artery disease
por: Lai, Hoang M., et al.
Publicado: (2012) -
T cell lymphoma presenting as esophageal obstruction and bronchoesophageal fistula
por: Sharma, Mala, et al.
Publicado: (2011) -
Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up
por: Gandhi, Kaushang, et al.
Publicado: (2010)